IQVIA Holdings Inc IQV

NYS: IQV | ISIN: US46266C1053 30/04/2025

155,07 USD (+1,06%)

(+1,06%) 30/04/2025

Toon enkel gratis nieuws

4 september 2024 · Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative · Persbericht

3 januari 2023 · Lasso announces a significant step forward in healthcare marketing measurement · Persbericht

28 december 2022 · Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer · Persbericht

12 mei 2021 · Malgré une tentative de désinformation, l'affaire antitrust contre IQVIA progresse et un rapport d'enquête de la FTC sur IQVIA est dévoilé · Persbericht

11 mei 2021 · Despite Disinformation Attempt, Antitrust Case Against IQVIA Moves Forward and Report of FTC Investigation of IQVIA Comes to Light · Persbericht

6 april 2021 · Moleculin Engages IQVIA to Manage Potential COVID-19 Clinical Trial · Persbericht

1 april 2021 · Quest Diagnostics Sells Ownership Interest in Q² Solutions to IQVIA · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe